🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will evaluate the safety, immunogenicity，immune persistence and l...
Status
Active Not Recruiting
Location
Neihuang County Center for Disease Control and Prevention
Start Date
2021-10-22
Trial ID
NCT05091619
Treatments Being Tested
This study is designed to assess the immunogenicity and safety of PENTAXIM™...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01214889
This study will assess both the antibody persistence of the investigational...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00303316
Treatments Being Tested
The purpose of this study is to provide further immunogenicity and safety i...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01031303
Treatments Being Tested
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901
As per request by the Heath Authorities, the present clinical study will as...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00453570
The study will assess the safety of Pentaxim® vaccine as a three-dose prima...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01491087
Treatments Being Tested
This study is a randomized, blinded, active-controlled phase I clinical tri...
Status
Recruiting
Location
Dazhu Center for Disease Prevention and Control
Start Date
2023-12-23
Trial ID
NCT06184542
The immunogenicity and safety of the adsorption of cell-free diphtheria and...
Status
Recruiting
Location
Yanshan County Center for Disease Control and Prevention
Start Date
2025-06-13
Trial ID
NCT07112144
Treatments Being Tested
The present clinical study will assess the immunogenicity as the primary ob...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00259337
Treatments Being Tested